Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Primary neuroendocrine carcinoma of the kidney

J. Dvorackova, J. Macak, P. Brzula, R. Tomanova, J. Dokulil

. 2013 ; 157 (3) : 257-260.

Jazyk angličtina Země Česko

Typ dokumentu kazuistiky, časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc14049956

BACKGROUND: The objective of the study was to report a rare case of primary neuroendocrine carcinoma of the right kidney in a 36 year old male. METHODS: The patient was clinically assessed; CT and OctreoScan scintigraphy were performed and levels of 5-HIAA, vanillylmandelic acid and NSE were determined. The tumor and metastases were histologically and immunohistochemically examined. RESULTS: The imaging methods showed a cystic tumor in the lower pole of the right kidney. Macroscopically, the entire tumor was sized 8x8x7 cm. Histologically, it was made up of ribbon-line or trabecular patterns of tumor cells. Occasional adenomatoid and cystic structures were present. The tumor cell nuclei were round or oval, with no irregularities and fine lumpy chromatin. The mitotic count was < 1 /10HPF and the proliferation marker Ki-67 was < 1 % of tumor cells. Immunohistochemically, the tumor cells were positive with antibodies against chromogranin A, synaptophysin, CD56 (focally), cytokeratins AE1-AE3 (focally), vimentin (most cells), glucagon (focally), and pancreatic polypeptide (PP; focally). Antibodies against serotonin, somatostatin, gastrin, vasoactive intestinal polypeptide (VIP) and calcitonin did not react with the tumor. The results of biochemical markers (5-HIAA, vanillylmandelic acid and NSE) did not correlate with development or treatment of the tumor. CONCLUSIONS: Primary neuroendocrine carcinoma of the kidney was diagnosed both histologically and immunohistochemically. The patient was clinically investigated using CT and OctreoScan scintigraphy. Within two years from nephrectomy, metastases were found in the right humerus and retrocaval lymph nodes. The metastatic lesions were surgically removed. Currently, the patient's condition is good, with no tumor progression detected.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc14049956
003      
CZ-PrNML
005      
20140328105928.0
007      
ta
008      
140325s2013 xr a f 000 0|eng||
009      
AR
024    7_
$a 10.5507/bp.2012.053 $2 doi
035    __
$a (PubMed)23073523
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Dvořáčková, Jana, $d 1956- $7 xx0077620 $u Department of Pathology, University Hospital and Faculty of Medicine University of Ostrava
245    10
$a Primary neuroendocrine carcinoma of the kidney / $c J. Dvorackova, J. Macak, P. Brzula, R. Tomanova, J. Dokulil
520    9_
$a BACKGROUND: The objective of the study was to report a rare case of primary neuroendocrine carcinoma of the right kidney in a 36 year old male. METHODS: The patient was clinically assessed; CT and OctreoScan scintigraphy were performed and levels of 5-HIAA, vanillylmandelic acid and NSE were determined. The tumor and metastases were histologically and immunohistochemically examined. RESULTS: The imaging methods showed a cystic tumor in the lower pole of the right kidney. Macroscopically, the entire tumor was sized 8x8x7 cm. Histologically, it was made up of ribbon-line or trabecular patterns of tumor cells. Occasional adenomatoid and cystic structures were present. The tumor cell nuclei were round or oval, with no irregularities and fine lumpy chromatin. The mitotic count was < 1 /10HPF and the proliferation marker Ki-67 was < 1 % of tumor cells. Immunohistochemically, the tumor cells were positive with antibodies against chromogranin A, synaptophysin, CD56 (focally), cytokeratins AE1-AE3 (focally), vimentin (most cells), glucagon (focally), and pancreatic polypeptide (PP; focally). Antibodies against serotonin, somatostatin, gastrin, vasoactive intestinal polypeptide (VIP) and calcitonin did not react with the tumor. The results of biochemical markers (5-HIAA, vanillylmandelic acid and NSE) did not correlate with development or treatment of the tumor. CONCLUSIONS: Primary neuroendocrine carcinoma of the kidney was diagnosed both histologically and immunohistochemically. The patient was clinically investigated using CT and OctreoScan scintigraphy. Within two years from nephrectomy, metastases were found in the right humerus and retrocaval lymph nodes. The metastatic lesions were surgically removed. Currently, the patient's condition is good, with no tumor progression detected.
650    _2
$a dospělí $7 D000328
650    _2
$a neuroendokrinní karcinom $x genetika $x patologie $7 D018278
650    _2
$a chromozomální aberace $7 D002869
650    _2
$a lidské chromozomy, pár 3 $x genetika $7 D002893
650    _2
$a diagnostické zobrazování $7 D003952
650    _2
$a lidé $7 D006801
650    _2
$a imunohistochemie $7 D007150
650    _2
$a nádory ledvin $x patologie $7 D007680
650    _2
$a mužské pohlaví $7 D008297
655    _2
$a kazuistiky $7 D002363
655    _2
$a časopisecké články $7 D016428
700    1_
$a Mačák, Jirka, $u Department of Pathology, University Hospital and Faculty of Medicine University of Ostrava $d 1940- $7 xx0006068
700    1_
$a Buzrla, Petr $u Department of Pathology, University Hospital and Faculty of Medicine University of Ostrava $7 xx0196924
700    1_
$a Tomanová, Radoslava $u Department of Pathology, University Hospital and Faculty of Medicine University of Ostrava $7 xx0181075
700    1_
$a Dokulil, Jiří $u Department of Oncology, University Hospital and Faculty of Medicine University of Ostrava $7 xx0074972
773    0_
$w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacký, Olomouc, Czech Republic $x 1213-8118 $g Roč. 157, č. 3 (2013), s. 257-260
910    __
$a ABA008 $b A 1502 $c 958 $y 4 $z 0
990    __
$a 20140325 $b ABA008
991    __
$a 20140328093039 $b ABA008
999    __
$a ok $b bmc $g 1017428 $s 848526
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2013 $b 157 $c 3 $d 257-260 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
LZP    __
$b NLK111 $a Pubmed-20140325

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...